T. Rowe Price Associates’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-26,200
| Closed | -$161K | – | 2627 |
|
|
2017
Q3 | $161K | Buy |
26,200
+12,700
| +94% | +$78K | ﹤0.01% | 2431 |
|
|
2017
Q2 | $98K | Buy |
13,500
+3,100
| +30% | +$22.5K | ﹤0.01% | 2482 |
|
|
2017
Q1 | $55K | Hold |
10,400
| – | – | ﹤0.01% | 2538 |
|
|
2016
Q4 | $75K | Hold |
10,400
| – | – | ﹤0.01% | 2494 |
|
|
2016
Q3 | $97K | Sell |
10,400
-92,201
| -90% | -$860K | ﹤0.01% | 2447 |
|
|
2016
Q2 | $648K | Hold |
102,601
| – | – | ﹤0.01% | 1854 |
|
|
2016
Q1 | $566K | Hold |
102,601
| – | – | ﹤0.01% | 1917 |
|
|
2015
Q4 | $573K | Buy |
102,601
+100
| +0.1% | +$558 | ﹤0.01% | 1900 |
|
|
2015
Q3 | $867K | Buy |
+102,501
| New | +$867K | ﹤0.01% | 1748 |
|